Early Stage Partners is a venture capital and private equity firm investing in early-stage companies operating in the Midwest of the United States that is headquartered in Cleveland, Ohio and was founded in 2001.
As of January 2020, Early Stage Partners has made 37 investments, 4 lead investments, and 6 exits. Notable investments made by Early Stage Partners include: HistoSonics, OnShift, Amplinifinity, CardiOx, Juventas Therapeutics, LineStream Technologies, CytoPherx, TAO Technologies, TetraLogic Pharmaceuticals, Reverse Medical, and Netilla Networks.
Early Stage Partners has raised 2 investments funds. The first fund, called ESP Fund I, launched in 2002, and the second fund, called ESP Fund II, launched in 2008.